Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 16 and up

Using antibiotics to prevent infections after jaw surgery

Official title: The Use of Single Dose vs Short-Term Peri-Operative Cefazolin in the Prevention of Surgical Site Infection Following Orthognathic Surgery

Run by Nova Scotia Health Authority · NCT05852158 · Data updated 2026-11-12

This study tests whether giving antibiotics before and after jaw surgery can help prevent infections in patients who are having surgery to fix jaw and facial problems.

Quick facts

PhasePhase 4
Study typeInterventional
Ages16 Years and up
SexAll
Enrollment400 (estimated)
SponsorNova Scotia Health Authority
Academic / other
Locations1 site (Halifax, Nova Scotia)
StatusRecruiting
StartedJanuary 9, 2024
Main results expectedJanuary 2027
Study endsJuly 2027
Registry record updatedMarch 19, 2026
Trial IDNCT05852158 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients aged 16 and older with ASA physical status classifications 1 and 2 who are scheduled for orthognathic surgery.

Probably not a fit

Patients with ASA classifications 3 and higher, recent antibiotic use, or those with systemic infections or immunosuppression may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of peri-operative antibiotics in reducing the incidence of surgical site infections (SSIs) following orthognathic surgery, which aims to correct jaw and facial deformities. The study will involve administering Cefazolin injections to patients undergoing these procedures, focusing on optimizing antibiotic protocols to minimize infection rates. Participants will be monitored for SSI occurrences post-surgery to evaluate the impact of the antibiotic regimen. The trial aims to establish a more effective approach to antibiotic use in this surgical context.

Why it matters

Potential benefit: If successful, this study could significantly reduce the rate of infections following orthognathic surgery, leading to better patient outcomes and reduced healthcare costs.

How similar studies have gone: Previous studies have shown that peri-operative antibiotics can reduce SSI rates in similar surgical contexts, indicating a potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All patients ASA 1 and 2 over the age of 16 undergoing orthognathic surgery will be offered participation in this study

Exclusion Criteria:

* Patients ASA 3 and higher, use of antibiotics in the preceding 2 weeks, presence of systemic, oral, or odontogenic infections, patients in a state of immunosuppression as a result of medications or systemic disease, patients with allergies to penicillins or cephalosporins, and patients who lack capacity for informed consent.

Where it's running

  • Victoria General Hospital
    Halifax, Nova Scotia, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.